Read now: Article in the Platform Life Science Magazine

 Download the whole issue with the title "Investing in Biotechnology"

The biotech scene in Germany is growing continuously, but the financing of clinical studies remains a challenging task. In his article, Dr. Thomas Prexl presents new ideas for the further development of start-up financing in the biotech sector. Heidelberg and the Rhine-Neckar region are therefore focusing on the early-stage financing of translational research. What does such financing look like?

Read the article here or download the entire issue as a PDF!

You will find the following contents in the journal:

  • Editorial Dare! Introduction 6 Invest in Biotech! Challenges and opportunities (Page 3)
  • Venture capital and the capital market are key The German biotech industry and its policies - challenges and possible solutions (Page 10)
  • "When it comes to drugs, artificial intelligence is highly interesting" Tech Talk - Interview with Dr Werner Lanthaler, Evotec (Page 14)
  • "The English language is an integral part of capital market communication" Interview with Marlen Schrader, Member of the Management Board and Chief Sales Officer, EnglishBusiness Legal (Page 16)
  • Chinese investments in the European biotechnology sector Overcoming challenges in cross-border collaborations Peter Homberg, Dentons (Page 18)
  • A full spectrum of options Managing your patent portfolio to satisfy investors' expectations Dr Andrea Schüßler, Huber & Schuessler Case Study (Page 20)
  • Added benefits through combinability Vira Therapeutics GmbH: Immunotherapy for cancer treatment (Page 22)
  • Who is Who in Life Sciences 3 industry players introduce themselves Financing (Page 24)
  • "The convergence of biotech and big data will have a strong impact on medicine" Interview with Dr Holger Reithinger, Forbion (Page 26)
  • New Visions! In North Rhine-Westphalia, business angels are playing an increasingly important role in financing biotech start-ups (Page 28)
  • Beyond Imagination Exploring the value that M Ventures brings to the start-up ecosystem Therese Liechtenstein, PhD, M Ventures (Page 30)
  • New funding concepts for translational projects Heidelberg and the RhineNeckar region are working on new ideas for biotech startup funding Dr Thomas Prexl, Heidelberg Startup Partners (Page 32)
  • "Risks and decisions are more readily taken, generally speaking Interview with Dr Alexander Schuth, Denali Therapeutics Capital Market & Investment (Page 34)
  • Another record year for US Biotech IPOs When will Europe join the party? Dr Marcus Wieprecht, MainFirst Bank (Page 36)
  • "The topic of IPOs is and will remain an interesting option for financing company growth" Interview with Sebastian Grabert, Euronext (Page 38)
  • Headwinds in European healthcare? Silicon Valley Bank's Nooman Haque on the 2019 outlook for Life Science Nooman Haque, Silicon Valley Bank's UK Branch Service 42 Partners' portraits (Page 40)
  • Event calendar (Page 44)

We wish you lots of joy reading!

This Website uses Cookies

We store technically necessary cookies, without which the operation of the site is not possible. In order to provide you with a better user experience on our website, we would also like to evaluate anonymous analysis data. Which tools we use for this purpose and further information can be found in our Privacy Policy and in our Legal Notice.

Accept technically required cookies only

On our website you will find interesting videos and maps hosted on YouTube/Google Maps. The videos and maps are used without a cookie, but data is still loaded from google servers, which means that your surfing behaviour can be recorded by Google.

Name Google Analytics
Anbieter Google LLC
Zweck Cookie von Goolge für Website-Analysen, mit dem statistische und anonymisierte Daten darüber erfasst werden, wie der Besucher die Website nutzt.
Cookie Name _ga,_gat,_gid
Cookie Laufzeit 14 Monate